Skip to Content

Join the 'Submental Fullness' group to help and get support from people like you.

Submental Fullness News

Related terms: Double Chin, Submental Fat Reduction

FDA Approves Kybella (deoxycholic acid) to Treat Submental Fullness, or 'Double Chin'

Posted 30 Apr 2015 by Drugs.com

April 29, 2015 – The U.S. Food and Drug Administration today approved Kybella (deoxycholic acid), a treatment for adults with moderate-to-severe fat below the chin, known as submental fat. Using Kybella for the treatment of fat outside of the submental area is not approved and is not recommended. Kybella is identical to the deoxycholic acid that is produced in the body. Deoxycholic acid produced in the body helps the body absorb fats. Kybella is a cytolytic drug, which when injected into tissue physically destroys the cell membrane. When properly injected into submental fat, the drug destroys fat cells; however, it can also destroy other types of cells, such as skin cells, if it is inadvertently injected into the skin. “Treatment with Kybella should only be provided by a licensed health care professional, and patients should fully understand the risks associated with use of the drug b ... Read more

Related support groups: Kybella, Submental Fullness, Deoxycholic Acid

Kybella Approved for Double Chin

Posted 29 Apr 2015 by Drugs.com

WEDNESDAY, April 29, 2015 – Kybella (deoxycholic acid) has been approved by the U.S. Food and Drug Administration to treat excess fat below the chin, a condition best known as "double chin." Kybella is identical to the body chemical deoxycholic acid, which helps absorb and destroy fats, the FDA said Wednesday in a news release. But the agency warned the drug is not meant to target fats elsewhere in the body, and could destroy healthy cells in the skin and elsewhere if injected improperly. The drug is approved to be injected into fat tissue in the "submental" area, located just below the chin. Kybella's safety and effectiveness were evaluated in clinical studies involving more than 1,000 people with moderate-to-severe submental fat. The drug can cause serious side effects, the agency warned, including nerve injury in the jaw, uneven smile, facial muscle weakness and trouble swallowing. ... Read more

Related support groups: Kybella, Submental Fullness, Deoxycholic Acid

FDA Approves Injected Drug for 'Double Chin'

Posted 29 Apr 2015 by Drugs.com

WEDNESDAY, April 29, 2015 – The U.S. Food and Drug Administration on Wednesday approved an injected drug to help aging Americans plagued what's commonly known as the "double chin." The drug, Kybella, contains deoxycholic acid, which the FDA says is "produced in the body [and] helps the body absorb fat." Kybella has been approved by the agency to treat adults with moderate-to-severe fat below the chin. "Treatment with Kybella should only be provided by a licensed health care professional, and patients should fully understand the risks associated with use of the drug before considering treatment," Dr. Amy Egan, deputy director of the Office of Drug Evaluation III at the FDA's Center for Drug Evaluation and Research, said in an agency news release. Just in case consumers contemplate using Kybella on other fat-prone parts of the body, Egan stressd that "Kybella is only approved for the ... Read more

Related support groups: Submental Fullness, Deoxycholic Acid

Ask a Question

Further Information

Related Condition Support Groups

Dermatological Disorders

Related Drug Support Groups

Kybella, deoxycholic acid